489 related articles for article (PubMed ID: 20068161)
1. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.
Harrison H; Farnie G; Howell SJ; Rock RE; Stylianou S; Brennan KR; Bundred NJ; Clarke RB
Cancer Res; 2010 Jan; 70(2):709-18. PubMed ID: 20068161
[TBL] [Abstract][Full Text] [Related]
2. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
[TBL] [Abstract][Full Text] [Related]
3. Notch4 Signaling Confers Susceptibility to TRAIL-Induced Apoptosis in Breast Cancer Cells.
Naik S; MacFarlane M; Sarin A
J Cell Biochem; 2015 Jul; 116(7):1371-80. PubMed ID: 25704336
[TBL] [Abstract][Full Text] [Related]
4. Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
Simões BM; O'Brien CS; Eyre R; Silva A; Yu L; Sarmiento-Castro A; Alférez DG; Spence K; Santiago-Gómez A; Chemi F; Acar A; Gandhi A; Howell A; Brennan K; Rydén L; Catalano S; Andó S; Gee J; Ucar A; Sims AH; Marangoni E; Farnie G; Landberg G; Howell SJ; Clarke RB
Cell Rep; 2015 Sep; 12(12):1968-77. PubMed ID: 26387946
[TBL] [Abstract][Full Text] [Related]
5. Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).
Reipas KM; Law JH; Couto N; Islam S; Li Y; Li H; Cherkasov A; Jung K; Cheema AS; Jones SJ; Hassell JA; Dunn SE
Oncotarget; 2013 Feb; 4(2):329-45. PubMed ID: 23593654
[TBL] [Abstract][Full Text] [Related]
6. Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer.
Bui QT; Im JH; Jeong SB; Kim YM; Lim SC; Kim B; Kang KW
Cancer Lett; 2017 Apr; 390():115-125. PubMed ID: 28108315
[TBL] [Abstract][Full Text] [Related]
7. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.
Rustighi A; Zannini A; Tiberi L; Sommaggio R; Piazza S; Sorrentino G; Nuzzo S; Tuscano A; Eterno V; Benvenuti F; Santarpia L; Aifantis I; Rosato A; Bicciato S; Zambelli A; Del Sal G
EMBO Mol Med; 2014 Jan; 6(1):99-119. PubMed ID: 24357640
[TBL] [Abstract][Full Text] [Related]
8. Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.
McGowan PM; Simedrea C; Ribot EJ; Foster PJ; Palmieri D; Steeg PS; Allan AL; Chambers AF
Mol Cancer Res; 2011 Jul; 9(7):834-44. PubMed ID: 21665937
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer stem cells: something out of notching?
Harrison H; Farnie G; Brennan KR; Clarke RB
Cancer Res; 2010 Nov; 70(22):8973-6. PubMed ID: 21045140
[TBL] [Abstract][Full Text] [Related]
10. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
11. Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G; Clarke RB
Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
[TBL] [Abstract][Full Text] [Related]
12. Dickkopf1 regulates fate decision and drives breast cancer stem cells to differentiation: an experimentally supported mathematical model.
Agur Z; Kirnasovsky OU; Vasserman G; Tencer-Hershkowicz L; Kogan Y; Harrison H; Lamb R; Clarke RB
PLoS One; 2011; 6(9):e24225. PubMed ID: 21915302
[TBL] [Abstract][Full Text] [Related]
13. Intraovarian regulation of gonadotropin-dependent folliculogenesis depends on notch receptor signaling pathways not involving Delta-like ligand 4 (Dll4).
Jovanovic VP; Sauer CM; Shawber CJ; Gomez R; Wang X; Sauer MV; Kitajewski J; Zimmermann RC
Reprod Biol Endocrinol; 2013 May; 11():43. PubMed ID: 23675950
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of breast cancer stem cells as evidenced with Notch-dependent and Notch-independent populations.
Wong NK; Fuller M; Sung S; Wong F; Karsan A
Cancer Med; 2012 Oct; 1(2):105-13. PubMed ID: 23342261
[TBL] [Abstract][Full Text] [Related]
15. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
16. Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.
Lombardo Y; Filipović A; Molyneux G; Periyasamy M; Giamas G; Hu Y; Trivedi PS; Wang J; Yagüe E; Michel L; Coombes RC
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16558-63. PubMed ID: 23012411
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.
Mine T; Matsueda S; Li Y; Tokumitsu H; Gao H; Danes C; Wong KK; Wang X; Ferrone S; Ioannides CG
Cancer Immunol Immunother; 2009 Aug; 58(8):1185-94. PubMed ID: 19048252
[TBL] [Abstract][Full Text] [Related]
18. Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity.
D'Angelo RC; Ouzounova M; Davis A; Choi D; Tchuenkam SM; Kim G; Luther T; Quraishi AA; Senbabaoglu Y; Conley SJ; Clouthier SG; Hassan KA; Wicha MS; Korkaya H
Mol Cancer Ther; 2015 Mar; 14(3):779-787. PubMed ID: 25673823
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway.
Du Z; Li J; Wang L; Bian C; Wang Q; Liao L; Dou X; Bian X; Zhao RC
Cancer Sci; 2010 Nov; 101(11):2417-24. PubMed ID: 20950370
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.
Pedrosa AR; Trindade A; Fernandes AC; Carvalho C; Gigante J; Tavares AT; Diéguez-Hurtado R; Yagita H; Adams RH; Duarte A
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1134-46. PubMed ID: 25767274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
